cp wire

CP Wire Articles

  • Allogene completed a $300 Million Series A round in April of 2018
  • Investors in the Series A round included Gilead and Pfizer


Allogene Therapeutics, Inc., a clinical-... read more

Thu, 09/6/18 - 09:37 am
  • VX-659 and VX-445 are next gen correctors
  • Correctors fix the defective CFTR protein so that it can move to the proper place on the cell surface
  • Vertex expects to submit an... read more
Thu, 09/6/18 - 09:20 am

Historical patent and exclusivity data for FDA-approved drugs now available

Hillsborough, New Jersey – September 5, 2018 – Bruce Pokras’ ... read more

Wed, 09/5/18 - 01:34 pm
  • Lenvima is the first new systemic therapy approved for the first-line treatment of unresectable HCC in China in ten years
  • In China, there are approximately 395,000 new cases of liver... read more
Wed, 09/5/18 - 09:24 am

EpicGenetics announced on9/5/18 that the U.S. Food and Drug Administration (FDA) has given approval to the Massachusetts General Hospital for a human clinical trial of BCG (an inexpensive generic... read more

Wed, 09/5/18 - 09:08 am

Pages